Contribution: Industrial Research Assistance Program – Contributions to Firms
Axolotl Biosciences Inc.
$25,000.00
Research and Development of HeartPrint bioink
FY 2021-22 · 2021-11-01
Summary
3D bioprinting enables the generation of human tissue models for screening potential drug targets in a more relevant fashion compared to animal models. This project is to perform the market research on what would be desirable features for the bioink capable of printing human cardiac tissues along with the initial R&D for this product.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Victoria|Victoria, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
740149539
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2021-11-01 | 2021-22 | $50,000.00 |
| 1 | 2021-11-01 | 2021-22 | $25,000.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The total amended value is -25,000 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La valeur totale des modifications est de - 25 000 dollars.
Agreement End Date
2022-04-30
Agreement Number
981586
Agreement Start Date
2021-11-01
Agreement Title
Research and Development of HeartPrint bioink
Agreement Title (French)
Recherche et développement de l'encre biologique HeartPrint
Agreement Type
Contribution
Agreement Value
$25,000.00
Amendment Date
2022-03-21
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
3D bioprinting enables the generation of human tissue models for screening potential drug targets in a more relevant fashion compared to animal models. This project is to perform the market research on what would be desirable features for the bioink capable of printing human cardiac tissues along with the initial R&D for this product.
Description (French)
La bio-impression 3D permet de générer des modèles de tissus humains pour le dépistage de cibles médicamenteuses potentielles de manière plus pertinente que les modèles animaux. Ce projet vise à réaliser une étude de marché sur les caractéristiques souhaitables d'une encre biologique capable d'imprimer des tissus cardiaques humains, ainsi que la R-D initiale de ce produit.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Victoria
Federal Riding (French)
Victoria
Federal Riding Number
59041
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
740149539
Recipient City
Victoria|Victoria
Recipient Country
CA
Recipient Legal Name
Axolotl Biosciences Inc.
Recipient Postal Code
V8W 2Y2
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2021-2022-Q3-981586
